Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50
(0.38%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma launches first generic version of Nexavar Tablets in US market
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
>>
Natco Pharma - Quaterly Results
>>
NATCO Pharma informs about certificate
>>
Natco Pharma jumps on launching first generic version of Revlimid along with Arrow International in US market
>>
Natco Pharma, Arrow International launch first generic version of Revlimid in U.S. market
>>
NATCO Pharma informs about issuance of duplicate share certificate
>>
NATCO Pharma informs about newspaper publication
>>
Natco Pharma reports 27% rise in Q3 consolidated net profit
<<
<
15
16
17
...52
>
>>